Why do AI projects fail in drug development and pharma? Insights from multi-year Pistoia Alliance studies.

Makarov VA, Sänger M, Saiz R, Hartung M, Lynch N

Open source

DOI
10.1007/s10822-026-00894-3
Published
2026 Aug 6
Container
Journal of computer-aided molecular design
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10822-026-00894-3,
  title = {Why do AI projects fail in drug development and pharma? Insights from multi-year Pistoia Alliance studies.},
  author = {Makarov VA and Sänger M and Saiz R and Hartung M and Lynch N},
  year = {2026},
  journal = {Journal of computer-aided molecular design},
  doi = {10.1007/s10822-026-00894-3},
  url = {https://doi.org/10.1007/s10822-026-00894-3}
}

RIS

TY  - JOUR
TI  - Why do AI projects fail in drug development and pharma? Insights from multi-year Pistoia Alliance studies.
AU  - Makarov VA
AU  - Sänger M
AU  - Saiz R
AU  - Hartung M
AU  - Lynch N
PY  - 2026
JO  - Journal of computer-aided molecular design
DO  - 10.1007/s10822-026-00894-3
UR  - https://doi.org/10.1007/s10822-026-00894-3
ER  - 

APA

VA, M., M, S., R, S., M, H., & N, L. (2026). Why do AI projects fail in drug development and pharma? Insights from multi-year Pistoia Alliance studies.. Journal of computer-aided molecular design. https://doi.org/10.1007/s10822-026-00894-3

Source records